Most Orphan Drugs Performing Poorly, Report Finds
Most Orphan Drugs Performing Poorly, Report Finds
Most Orphan Drugs Performing Poorly, Report Finds
The latest annual report from Trinity Partners has found that orphan disease drugs often perform poorly at launch and continue to underachieve after three years of sales. At the other end of the spectrum, the most successful drugs on the market were for non-orphan diseases such as cancer and HIV.
Most Orphan Drugs Performing Poorly, Report Finds
No-Incision CRISPR Reduces Genetic Obesity in Mice
No-Incision CRISPR Reduces Genetic Obesity in Mice
No-Incision CRISPR Reduces Genetic Obesity in Mice
A modified version of CRISPR has been used to reverse genetic obesity in two different mouse models without editing any genes. The technique uses the guidance system in CRISPR to target certain genetic sequences and amplifies existing gene activity to ramp up protein production.
No-Incision CRISPR Reduces Genetic Obesity in Mice
Comprehensive Study Uncovers Hidden Networks Affecting Mental Illness
Comprehensive Study Uncovers Hidden Networks Affecting Mental Illness
Comprehensive Study Uncovers Hidden Networks Affecting Mental Illness
The first findings from a comprehensive genomic analysis of the human brain have been unveiled, potentially uncovering a good deal about the inherited component of diseases such as schizophrenia and autism.
Comprehensive Study Uncovers Hidden Networks Affecting Mental Illness
International Study Finds 11 New Epilepsy Genes
International Study Finds 11 New Epilepsy Genes
International Study Finds 11 New Epilepsy Genes
Eleven new genes associated with epilepsy have been discovered by an international team of scientists, advancing knowledge of the underlying causes of the condition and potentially helping in the development of new treatments.
International Study Finds 11 New Epilepsy Genes
Reprogrammed Skin Cells Shrink Mouse Tumours
Reprogrammed Skin Cells Shrink Mouse Tumours
Reprogrammed Skin Cells Shrink Mouse Tumours
Personalised tumour-detecting cells from adult skin cells have been used to shrink brain tumours in mice by up to 5%, scientists have revealed. While the strategy has not yet been fully tested in people, it could in the future give doctors the ability to develop a custom treatment for certain cancer types.
Reprogrammed Skin Cells Shrink Mouse Tumours

Breaking News

Most Orphan Drugs Performing Poorly, Report Finds

The latest annual report from Trinity Partners has found that orphan disease drugs often perform poorly at launch and continue to underachieve after three years of sales. At the other end of the spectrum, the most successful drugs on the market were for non-orphan diseases such as cancer and HIV.

No-Incision CRISPR Reduces Genetic Obesity in Mice

A modified version of CRISPR has been used to reverse genetic obesity in two different mouse models without editing any genes. The technique uses the guidance system in CRISPR to target certain genetic sequences and amplifies existing gene activity to ramp up protein production.

International Study Finds 11 New Epilepsy Genes

Eleven new genes associated with epilepsy have been discovered by an international team of scientists, advancing knowledge of the underlying causes of the condition and potentially helping in the development of new treatments.

Reprogrammed Skin Cells Shrink Mouse Tumours

Personalised tumour-detecting cells from adult skin cells have been used to shrink brain tumours in mice by up to 5%, scientists have revealed. While the strategy has not yet been fully tested in people, it could in the future give doctors the ability to develop a custom treatment for certain cancer types.

Amgen and Entera Collaborate on Serious Illness Treatment Program

Amgen and Entera Bio are partnering up to develop new treatments for inflammatory disease and certain other serious illnesses using the Entera drug discovery program. The platform will be used to develop oral formulations for one preclinical large molecule program which Amgen has selected. Entera’s CEO said the collaboration would be an important validation test of the platform technology.

Magazines and Educational Guides

Sequencing Buyers’ Guide

The development of the first automated DNA sequencers completely revolutionized the field of DNA sequencing and, eventually, made it possible to publish the first draft sequences of the human genome. Since then, a whole host of companies have developed their own approaches to DNA sequencing, resulting in a market that is filled with different possibilities […]

Molecular Diagnostics Report

Read our report on all things Molecular Diagnostics, including some great contributed articles. Need to know about liquid biopsies? Want to know what the current regulatory landscape looks like? Then you’ve come to the right place.

Gene Editing 101: 2018 Edition

Free download: This guide will discuss the gene editing tools currently available and how they can be used to manipulate genomic sequences, as well as the real world applications that put these tools to use.

The Genome Spot / Webinars

Maize genome complexity traversed with Oxford Nanopore technology

  Maize is one of the most economically important crops globally and much effort has been spent generating the high quality B73 reference genome. However, the 10 chromosome, 2.3 gigabase (Gb) B73 reference genome was a substantial challenge due to the fact it is comprised of 85% transposable elements, 75% of which are long terminal […]

Human genome sequencing on PromethION: characterization of structural variants and repetitive regions

  At the VIB-UAntwerp Center for Molecular Neurology, we apply sequencing technologies to elucidate the genetic etiology of neurodegenerative brain diseases such as Alzheimer Disease and Frontotemporal Dementia. Structural variation and repetitive regions are insufficiently characterized using currently dominant short-read sequencing technologies. Long-read sequencing on the Oxford Nanopore PromethION has the potential for a comprehensive […]

Opinions

GWAS Coming Of Age

There’s a fantastic editorial over in nature medicine that you should really take a look at, if you’re interested in finding out more about where the future of GWAS might be heading.

Educate Yourself

Making Pregnancy Safer

Non-Invasive Pre-Natal Testing (NIPT) has the potential of bringing safer pregnancy testing to the wider NHS, but not without its challenges.

65 Years of DNA

Happy DNA Day! To celebrate, we’ve put together a timeline of some of the major events that have happened in genomics since 1953 – See how far we’ve come!

Front Line Genomics Exclusives

Communicating Genomic Progress

Genomics is the science of people, but how can you get members of the public to engage with a topic that they may not understand?

Around the Web

Blog

Weekend Reads

This week: Are the conclusion about ‘alien’ mummy, Ata correct? Where is the African DNA in the search for cures? And is it possible to bury family secrets in the age of DNA testing? 

Weekend Reads

This week: Are we really running out of data storage? And can a deadly infection be genetic? You’ll also get a list of must-reads this summer… 

Weekend Reads

This week: Reversed ageing, pig organs, the future of humankind and citizen scientists using genetics to solve past crimes.